Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
For a more detailed look at peptide safety across compounds, review our safety guide
Its selective biochemical profile and favorable safety characteristics make it suitable for advanced studies on NAD+ metabolism, mitochondrial function, and metabolic health
The clinical drug development program was halted in 2007 after the pivotal Phase IIb trial did not show statistically significant weight loss in the primary endpoint
Clinical data shows that most participants in tirzepatide trials regained significant weight within one year of stopping treatment
US$ 23.80
US$ 23.49
US$ 28.48
US$ 24.13
US$ 24.42
